Adriamycin-associated cardiomyopathy: Where are we now updates in pathophysiology, dose recommendations, prognosis, and outcomes

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Adriamycin-associated cardiomyopathy: Where are we now updates in pathophysiology, dose recommendations, prognosis, and outcomes'. Together they form a unique fingerprint.

Medicine & Life Sciences